|

New Asbestos Test May Help Protect Against Mesothelioma

20172425_microscope2

Although it is known to cause mesothelioma and a host of other diseases, asbestos is still in use in workplaces around the world. According to the Occupational Safety and Health Administration (OSHA), as many as 1.3 million Americans are exposed to significant amounts of asbestos in the workplace.

Historically, those who mine the raw material are at greatest risk for mesothelioma, along with those who work in construction or in manufacturing asbestos-containing products. Inhaled fibers can cause irritation and inflammation that can trigger mesothelioma and other asbestos related diseases even decades after exposure.

Because higher concentrations of airborne asbestos increase the health risk, workplace monitoring of airborne asbestos is required to help protect workers from mesothelioma and other diseases.  Phase contrast microscopy (PCM) is one of the most common methods used. With PCM, a sample is collected on a mixed cellulose ester membrane filter which is then cleared with a chemical solution and the collected fibers are counted under 400x magnification.  But PCM requires a high degree of sophistication on the part of the microscopist performing the test.  It is also not capable of distinguishing between asbestos and non-asbestos fibers, so all the fibers that meet the counting criteria are counted as asbestos.

Now a group of mechanical engineers in South Korea have developed a an automated system using high-throughput microscopy (HTM) that they say can quickly and accurately distinguish asbestos fibers from other particles on a sample slide. To test the effectiveness of the HTM system, the researchers used the method to measure known concentrations of airborne asbestos at 11 different workplaces where asbestos is used.  The results showed “a reasonably good agreement in the asbestos concentration” when compared with conventional testing methods. Because of HTM’s accuracy and higher efficiency, the team suggests that it be considered as an alternative to conventional PCM for preventing mesothelioma and other asbestos related diseases through onsite workplace monitoring.

Mesothelioma is a particularly difficult cancer to treat and nearly all cases would have been avoidable if asbestos had been previously removed from products and workplaces.  The fact that asbestos is still ubiquitous means that people of all ages are still being potentially exposed to this mesothelioma-causing carcinogen.  New automated tests like HTM may help protect workers from being diagnosed with mesothelioma in the future.

Sources:

Cho, M et al, “Automated Counting of Airborne Asbestos Fibers by a High-Throughput Microscopy (HTM) Method”, November 2011, Sensors.

Polarized Light Microscopy of Asbestos, Occupational Safety and Health Administration website,

Explanation of Phase Contrast Microscopy (PCM), Abacon Environmental Consultants, Inc.

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…